301267 Stock Overview
Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Rewards
Risk Analysis
No risks detected for 301267 from our risk checks.
Huaxia Eye Hospital Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.12 |
| 52 Week High | CN¥57.73 |
| 52 Week Low | CN¥23.50 |
| Beta | 0 |
| 1 Month Change | -4.32% |
| 3 Month Change | -6.75% |
| 1 Year Change | -54.87% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -52.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 301267 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 4.9% | 2.9% | 4.2% |
| 1Y | -54.9% | -33.5% | -13.2% |
Return vs Industry: 301267 underperformed the CN Healthcare industry which returned -33.5% over the past year.
Return vs Market: 301267 underperformed the CN Market which returned -13.2% over the past year.
Price Volatility
| 301267 volatility | |
|---|---|
| 301267 Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 301267 has not had significant price volatility in the past 3 months.
Volatility Over Time: 301267's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 7,613 | Qingcan Su | www.huaxiaeye.com |
Huaxia Eye Hospital Group Co.,Ltd. operates an ophthalmic medical chain in China and internationally. The company provides general ophthalmology diagnosis and treatment services for patients with ophthalmic diseases.
Huaxia Eye Hospital Group Co.,Ltd. Fundamentals Summary
| 301267 fundamental statistics | |
|---|---|
| Market cap | CN¥21.80b |
| Earnings (TTM) | CN¥671.57m |
| Revenue (TTM) | CN¥4.06b |
32.5x
P/E Ratio5.4x
P/S RatioIs 301267 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 301267 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.06b |
| Cost of Revenue | CN¥2.07b |
| Gross Profit | CN¥1.99b |
| Other Expenses | CN¥1.32b |
| Earnings | CN¥671.57m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.80 |
| Gross Margin | 48.98% |
| Net Profit Margin | 16.54% |
| Debt/Equity Ratio | 0.4% |
How did 301267 perform over the long term?
See historical performance and comparison